“…This level of sensitivity has made ddPCR an attractive modality in detecting rare mutations associated with cancer phenotypes in liquid biopsies (Oellerich et al., ), as well as in low‐level pathogen detection (Mu, Yan, Tang, & Liao, ; Roberts et al., ; Sedlak, Cook, Cheng, Magaret, & Jerome, ; Srisutham et al., ; Strain et al., ; Wilson et al., ). Indeed, ddPCR has been used to detect HIV DNA, with single targets of 60 to 80 nucleotides [reviewed in Rutsaert, Bosman, Trypsteen, Nijhuis, and Vandekerckhove (); also see Trypsteen, Kiselinova, Vandekerckhove, and De Spiegelaere ()]. In particular, ddPCR has been implemented to quantify total HIV DNA in peripheral blood cells including PBMCs, CD4+ T cells (de Oliveira et al., ; Eriksson et al., ; Henrich, Gallien, Li, Pereyra, & Kuritzkes, ; Kiselinova et al., ; Strain et al., ), and regulatory T cells (Treg; Dunay et al., ), as well as in cells from the central nervous system (de Oliveira et al., ).…”